celiac disease
NIMA Partners, EmpowerDx Collaborate on Celiac Gene Test
The assay from EmpowerDx uses self-collected oral swabs to identify genetic risk for the autoimmune disease, and the companies offer results within 10 business days.
FDA Clears Inova Diagnostics Digital Multianalyte System, Celiac Test
The system uses particle-based multianalyte technology that allows it to deliver up to 720 results per hour using a 12-analyte test cartridge.
Adaptive Biotechnologies ImmunoSeq Dx Development Jolts Forward With Lyme Disease in Crosshairs
Premium
The immune sequencing firm has engaged the FDA in discussions over how to get regulatory approval for one test for several seemingly different diseases.
ProciseDx, Lumiphore Ink Partnership for Rapid Point-of-Care Tests
ProciseDx anticipates bringing rapid, quantitative point-of-care tests to market in 2020 using Lumiphore's metal luminescent reporter technology.
After Spin Off From Prometheus, ProciseDx Targets POC Tests for Inflammatory, Autoimmune Conditions
Premium
The firm is conducting clinical trials in preparation for applying for FDA clearance to market its POC instrument and first assay in the first quarter of next year.